We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Nerve Stimulation Implant May Aid Depression

By HospiMedica staff writers
Posted on 04 Jan 2001
A pilot study involving patients with pharmacotherapy-resistant depression indicates that the use of vagus nerve stimulation (VNS) has the potential to bring about sustained improvement in such patients.

VNS therapy is delivered by an implantable medical device similar to a cardiac pacemaker called the NCP System, developed by Cyberonics, Inc. More...
(Houston, TX, USA). A stopwatch-sized generator is implanted in the left chest and a nerve stimulation electrode is attached to the vagus nerve in the neck, typically on an outpatient basis. Using an external programmer, a doctor can set or reset the stimulation parameters of the device. The system delivers preprogrammed intermittent electrical pulses to the vagus nerve 24 hours a day. The system has been approved by the U.S. Food and Drug Administration (FDA) for adjunctive therapy for the treatment of medically refractory partial onset seizures in adults and adolescents over 12. The system is not yet authorized for the treatment of depression.

A pivotal study involving 102 patients at 20 U.S. sites is now under way. In addition, enrollment has begun for a multicenter European study, beginning at Beaumont Hospital in Dublin (Ireland), an important neuroscience center in Ireland. "We are extremely excited to begin the clinical trial, as VNS therapy represents a new milestone in the treatment of patients with depression,” said Veronica O'Keane, M.D., psychiatrist at Beaumont Hospital and principal investigator in the European study.



Related Links:
Cyberonics

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
ECG Management System
NEMS Web
Digital X-Ray Detector Panel
Acuity G4
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.